90R1728 KRM-D
 
  By: Plesa H.B. No. 214
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the authority of the Cancer Prevention and Research
  Institute of Texas to award grants for endometriosis research.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 102.002, Health and Safety Code, is
  amended to read as follows:
         Sec. 102.002.  PURPOSES. The Cancer Prevention and Research
  Institute of Texas is established to:
               (1)  create and expedite innovation in the area of
  cancer research and in enhancing the potential for a medical or
  scientific breakthrough in the prevention of cancer and cures for
  cancer, including research on whether endometriosis may lead to or
  increase the incidence of cancer in humans;
               (2)  attract, create, or expand research capabilities
  of public or private institutions of higher education and other
  public or private entities that will promote a substantial increase
  in cancer research and in the creation of high-quality new jobs in
  this state; and
               (3)  develop and implement the Texas Cancer Plan.
         SECTION 2.  Section 102.051(a), Health and Safety Code, is
  amended to read as follows:
         (a)  The institute:
               (1)  may award [make] grants to provide funds to public
  or private persons to implement the Texas Cancer Plan, and may award
  [make] grants to institutions of learning and to advanced medical
  research facilities and collaborations in this state for:
                     (A)  research into the causes of and cures for all
  types of cancer in humans, including research on whether
  endometriosis leads to or increases the incidence of cancer and the
  causes of, biological markers of, and treatment efficacy for
  endometriosis;
                     (B)  facilities for use in research into the
  causes of and cures for cancer;
                     (C)  research, including translational research,
  to develop therapies, protocols, medical pharmaceuticals, or
  procedures for the cure or substantial mitigation of all types of
  cancer in humans; and
                     (D)  cancer prevention and control programs in
  this state to mitigate the incidence of all types of cancer in
  humans;
               (2)  may support institutions of learning and advanced
  medical research facilities and collaborations in this state in all
  stages in the process of finding the causes of all types of cancer
  in humans and developing cures, from laboratory research to
  clinical trials and including programs to address the problem of
  access to advanced cancer treatment;
               (3)  may establish the appropriate standards and
  oversight bodies to ensure the proper use of funds authorized under
  this chapter for cancer research and facilities development;
               (4)  may employ necessary staff to provide
  administrative support;
               (5)  shall continuously monitor contracts and
  agreements authorized by this chapter and ensure that each grant
  recipient complies with the terms and conditions of the grant
  contract;
               (6)  shall ensure that all grant proposals comply with
  this chapter and rules adopted under this chapter before the
  proposals are submitted to the oversight committee for approval;
  and
               (7)  shall establish procedures to document that the
  institute, its employees, and its committee members appointed under
  this chapter comply with all laws and rules governing the peer
  review process and conflicts of interest.
         SECTION 3.  Section 102.201(c), Health and Safety Code, is
  amended to read as follows:
         (c)  The fund may be used only to pay for:
               (1)  grants for cancer research and for cancer research
  facilities in this state to realize therapies, protocols, and
  medical procedures for the cure or substantial mitigation of all
  types of cancer in humans, including research on whether
  endometriosis leads to or increases the incidence of cancer and the
  causes of, biological markers of, and treatment efficacy for
  endometriosis;
               (2)  the purchase, subject to approval by the
  institute, of laboratory facilities by or on behalf of a state
  agency or grant recipient;
               (3)  grants to public or private persons to implement
  the Texas Cancer Plan;
               (4)  the operation of the institute;
               (5)  grants for cancer prevention and control programs
  in this state to mitigate the incidence of all types of cancer in
  humans; and
               (6)  debt service on bonds issued as authorized by
  Section 67, Article III, Texas Constitution.
         SECTION 4.  This Act takes effect September 1, 2027.